765 related articles for article (PubMed ID: 10496594)
1. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of nuclear DNA content in chondrosarcoma.
Kreicbergs A; Zetterberg A; Söderberg G
Anal Quant Cytol; 1980 Dec; 2(4):272-9. PubMed ID: 7469202
[TBL] [Abstract][Full Text] [Related]
3. Relationship between histologic grade and cytofluorometric cellular DNA and RNA content in primary bone tumors.
Takeshita H; Kusuzaki K; Kuzuhara A; Tsuji Y; Ashihara T; Gebhardt MC; Mankin HJ; Springfield DS; Hirasawa Y
Anticancer Res; 2001; 21(2B):1271-7. PubMed ID: 11396198
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.
Van den Berg E; Van Oven MW; de Jong B; Dam A; Wiersema J; Dijkhuizen T; Hoekstra HJ; Molenaar WM
Lab Invest; 1994 Mar; 70(3):307-13. PubMed ID: 8145525
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma.
Bovée JV; Cleton-Jansen AM; Kuipers-Dijkshoorn NJ; van den Broek LJ; Taminiau AH; Cornelisse CJ; Hogendoorn PC
Genes Chromosomes Cancer; 1999 Nov; 26(3):237-46. PubMed ID: 10502322
[TBL] [Abstract][Full Text] [Related]
6. [Determination of malignancy of cartilaginous tumors (2). Determination of malignancy by nuclear DNA contents and their distribution patterns in cartilaginous tumors].
Lin CP; Higaki S; Takeyama S; Nakata T; Akai M; Tateishi A; Abe M
Nihon Seikeigeka Gakkai Zasshi; 1983 Jun; 57(6):617-28. PubMed ID: 6619626
[TBL] [Abstract][Full Text] [Related]
7. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric determination of DNA content in malignant and benign bone tumours.
Heliö H; Karaharju E; Nordling S
Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218
[TBL] [Abstract][Full Text] [Related]
9. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
[TBL] [Abstract][Full Text] [Related]
10. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome.
Agarwal V; Greenebaum E; Wersto R; Koss LG
Arch Pathol Lab Med; 1991 Jun; 115(6):558-62. PubMed ID: 2039341
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization in cartilaginous tumors.
Ozaki T; Wai D; Schäfer KL; Lindner N; Böcker W; Winkelmann W; Dockhorn-Dworniczak B; Poremba C
Anticancer Res; 2004; 24(3a):1721-5. PubMed ID: 15274346
[TBL] [Abstract][Full Text] [Related]
13. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
15. DNA cytofluorometric analysis of benign and malignant nerve sheath tumors.
Tsuji Y; Kusuzaki K; Kuzuhara A; Murata H; Takeshita H; Hirata M; Hashiguchi S; Hirasawa Y; Ashihara T
Anticancer Res; 2000; 20(6C):4691-6. PubMed ID: 11205202
[TBL] [Abstract][Full Text] [Related]
16. p53 expression and DNA ploidy of cartilage lesions.
Coughlan B; Feliz A; Ishida T; Czerniak B; Dorfman HD
Hum Pathol; 1995 Jun; 26(6):620-4. PubMed ID: 7774891
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the c-myc proto-oncogene in human chondrosarcoma.
Castresana JS; Barrios C; Gómez L; Kreicbergs A
Diagn Mol Pathol; 1992 Dec; 1(4):235-8. PubMed ID: 1342971
[TBL] [Abstract][Full Text] [Related]
18. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy analysis of pediatric germ cell tumors.
Silver SA; Wiley JM; Perlman EJ
Mod Pathol; 1994 Dec; 7(9):951-6. PubMed ID: 7892165
[TBL] [Abstract][Full Text] [Related]
20. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.
Pinto AE; Fonseca I; Soares J
Cancer; 1999 Jan; 85(2):273-81. PubMed ID: 10023692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]